ASHP injectable drug information : a comprehensive guide to compatibility and stability / / American Society of Health-System Pharmacists |
Pubbl/distr/stampa | [Place of publication not identified] : , : American Society of Health-System Pharmacists, , 2021 |
Descrizione fisica | 1 online resource (1,756 pages) |
Disciplina | 615 |
Soggetto topico |
Incompatibles (Pharmacy)
Drug stability Injections |
ISBN |
9781585286584
9781585286850 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910794432003321 |
[Place of publication not identified] : , : American Society of Health-System Pharmacists, , 2021 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
ASHP injectable drug information : a comprehensive guide to compatibility and stability / / American Society of Health-System Pharmacists |
Pubbl/distr/stampa | [Place of publication not identified] : , : American Society of Health-System Pharmacists, , 2021 |
Descrizione fisica | 1 online resource (1,756 pages) |
Disciplina | 615 |
Soggetto topico |
Incompatibles (Pharmacy)
Drug stability Injections |
ISBN |
9781585286584
9781585286850 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910815639103321 |
[Place of publication not identified] : , : American Society of Health-System Pharmacists, , 2021 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Botulinum neurotoxin injection manual / / editors, Katharine E. Alter, Nicole A. Wilson |
Pubbl/distr/stampa | New York, New York : , : Demos Medical, , 2015 |
Descrizione fisica | 1 online resource (369 p.) |
Disciplina | 615.7/78 |
Soggetto topico |
Botulinum toxin - Therapeutic use
Injections Nervous system - Diseases - Treatment |
Soggetto genere / forma | Electronic books. |
ISBN | 1-61705-209-4 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; Share Botulinum Neurotoxin Injection Manual; Section One: Botulinum Neurotoxin: Basic Science and Reconstitution; Chapter 1: Pharmacology of Botulinum Neurotoxins; Normal Neurotransmitter Release; BoNTs Synthesis and Structure; BoNT Binding/Blocking; BoNT Potency and Dosing; Clinical Implications of BoNT Pharmacology; Antigenicity, Antibody Formation, and Nonresponsiveness to BoNT; Safety; Central Effects of BoNTs; Summary; Chapter 2: Comparison of Botulinum Neurotoxin Products; BoNT Approvals
BoNT Products: Antigenicity, Dilution, and DiffusionBoNT Products: Potency and Dose; Converting Units/Dose Among BoNT Products; Summary; Chapter 3: Neurotoxin Storage, Reconstitution, Handling, and Dilution; Serotype B BoNT; Serotype A BoNTs; OnabotulinumtoxinA (Botox®) Reconstitution and Handling; AbobotulinumtoxinA (Dysport®) Reconstitution and Handling; IncobotulinumtoxinA (Xeomin®) Reconstitution and Handling; RimabotulinumtoxinB (Myobloc® in the United States, NeuroBloc® Outside the United States) Reconstitution and Handling; Injection Supplies; Needle Selection Chapter 4: Guidance Techniques for Botulinum Neurotoxin InjectionsAnatomic Reference Guides, Surface Anatomy, and Palpation Guidance; EMG Guidance; Electrical Stimulation Guidance; B-Mode Ultrasound; Combinations of Techniques; Other Guidance Techniques for BoNT Injections; Summary; Chapter 5: Phenol Nerve Blocks; Why Consider Phenol Neurolysis?; Phenol Mechanism of Action; Muscle Hypertonia; Pattern of Involvement; Injection Technique and Dosing; Musculocutaneous Nerve; Obturator Nerve; Tibial Motor Nerves; Summary; Section Two: Clinical Applications of Botulinum Neurotoxins Part I: Botulinum Neurotoxins for the Treatment of Muscle Overactivity Associated with Focal Dystonia Syndromes and Upper Motor Neuron SyndromesCraniofacial Dystonia; Chapter 6: Benign Essential Blepharospasm; Chapter 7: Botulinum Neurotoxin Therapy for Hemifacial Spasm; Chapter 8: Botulinum Neurotoxin Injections for Oromandibular Dystonias; Illustrations for Craniofacial Dystonia; Cervical Dystonia; Chapter 9: Botulinum Neurotoxin Injections for Cervical Dystonia; Illustrations for Cervical Dystonia; Upper Limb, Lower Limb, and Trunk Dystonia Chapter 10: Botulinum Neurotoxin for the Treatment of Idiopathic Primary Focal Limb DystoniaChapter 11: Botulinum Neurotoxin for Treatment of Muscle Overactivity Associated with Upper Motor Neuron Syndromes; Chapter 12: Botulinum Neurotoxin for the Treatment of Trunk Dystonia/Camptocormia; Chapter 13: Botulinum Neurotoxin Injections for the Treatment of Tremor; Illustrations for Upper Limb, Lower Limb, and Trunk Dystonia; Part II: Botulinum Neurotoxins for Neurosecretory Disorders; Chapter 14: Botulinum Neurotoxin Therapy for Problematic Sialorrhea; Condition Chapter 15: Botulinum Neurotoxin Therapy for Hyperhidrosis |
Record Nr. | UNINA-9910463779103321 |
New York, New York : , : Demos Medical, , 2015 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Botulinum neurotoxin injection manual / / editors, Katharine E. Alter, Nicole A. Wilson |
Pubbl/distr/stampa | New York, New York : , : Demos Medical, , 2015 |
Descrizione fisica | 1 online resource (369 p.) |
Disciplina | 615.7/78 |
Soggetto topico |
Botulinum toxin - Therapeutic use
Injections Nervous system - Diseases - Treatment |
ISBN | 1-61705-209-4 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; Share Botulinum Neurotoxin Injection Manual; Section One: Botulinum Neurotoxin: Basic Science and Reconstitution; Chapter 1: Pharmacology of Botulinum Neurotoxins; Normal Neurotransmitter Release; BoNTs Synthesis and Structure; BoNT Binding/Blocking; BoNT Potency and Dosing; Clinical Implications of BoNT Pharmacology; Antigenicity, Antibody Formation, and Nonresponsiveness to BoNT; Safety; Central Effects of BoNTs; Summary; Chapter 2: Comparison of Botulinum Neurotoxin Products; BoNT Approvals
BoNT Products: Antigenicity, Dilution, and DiffusionBoNT Products: Potency and Dose; Converting Units/Dose Among BoNT Products; Summary; Chapter 3: Neurotoxin Storage, Reconstitution, Handling, and Dilution; Serotype B BoNT; Serotype A BoNTs; OnabotulinumtoxinA (Botox®) Reconstitution and Handling; AbobotulinumtoxinA (Dysport®) Reconstitution and Handling; IncobotulinumtoxinA (Xeomin®) Reconstitution and Handling; RimabotulinumtoxinB (Myobloc® in the United States, NeuroBloc® Outside the United States) Reconstitution and Handling; Injection Supplies; Needle Selection Chapter 4: Guidance Techniques for Botulinum Neurotoxin InjectionsAnatomic Reference Guides, Surface Anatomy, and Palpation Guidance; EMG Guidance; Electrical Stimulation Guidance; B-Mode Ultrasound; Combinations of Techniques; Other Guidance Techniques for BoNT Injections; Summary; Chapter 5: Phenol Nerve Blocks; Why Consider Phenol Neurolysis?; Phenol Mechanism of Action; Muscle Hypertonia; Pattern of Involvement; Injection Technique and Dosing; Musculocutaneous Nerve; Obturator Nerve; Tibial Motor Nerves; Summary; Section Two: Clinical Applications of Botulinum Neurotoxins Part I: Botulinum Neurotoxins for the Treatment of Muscle Overactivity Associated with Focal Dystonia Syndromes and Upper Motor Neuron SyndromesCraniofacial Dystonia; Chapter 6: Benign Essential Blepharospasm; Chapter 7: Botulinum Neurotoxin Therapy for Hemifacial Spasm; Chapter 8: Botulinum Neurotoxin Injections for Oromandibular Dystonias; Illustrations for Craniofacial Dystonia; Cervical Dystonia; Chapter 9: Botulinum Neurotoxin Injections for Cervical Dystonia; Illustrations for Cervical Dystonia; Upper Limb, Lower Limb, and Trunk Dystonia Chapter 10: Botulinum Neurotoxin for the Treatment of Idiopathic Primary Focal Limb DystoniaChapter 11: Botulinum Neurotoxin for Treatment of Muscle Overactivity Associated with Upper Motor Neuron Syndromes; Chapter 12: Botulinum Neurotoxin for the Treatment of Trunk Dystonia/Camptocormia; Chapter 13: Botulinum Neurotoxin Injections for the Treatment of Tremor; Illustrations for Upper Limb, Lower Limb, and Trunk Dystonia; Part II: Botulinum Neurotoxins for Neurosecretory Disorders; Chapter 14: Botulinum Neurotoxin Therapy for Problematic Sialorrhea; Condition Chapter 15: Botulinum Neurotoxin Therapy for Hyperhidrosis |
Record Nr. | UNINA-9910788065803321 |
New York, New York : , : Demos Medical, , 2015 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Botulinum neurotoxin injection manual / / editors, Katharine E. Alter, Nicole A. Wilson |
Pubbl/distr/stampa | New York, New York : , : Demos Medical, , 2015 |
Descrizione fisica | 1 online resource (369 p.) |
Disciplina | 615.7/78 |
Soggetto topico |
Botulinum toxin - Therapeutic use
Injections Nervous system - Diseases - Treatment |
ISBN | 1-61705-209-4 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; Share Botulinum Neurotoxin Injection Manual; Section One: Botulinum Neurotoxin: Basic Science and Reconstitution; Chapter 1: Pharmacology of Botulinum Neurotoxins; Normal Neurotransmitter Release; BoNTs Synthesis and Structure; BoNT Binding/Blocking; BoNT Potency and Dosing; Clinical Implications of BoNT Pharmacology; Antigenicity, Antibody Formation, and Nonresponsiveness to BoNT; Safety; Central Effects of BoNTs; Summary; Chapter 2: Comparison of Botulinum Neurotoxin Products; BoNT Approvals
BoNT Products: Antigenicity, Dilution, and DiffusionBoNT Products: Potency and Dose; Converting Units/Dose Among BoNT Products; Summary; Chapter 3: Neurotoxin Storage, Reconstitution, Handling, and Dilution; Serotype B BoNT; Serotype A BoNTs; OnabotulinumtoxinA (Botox®) Reconstitution and Handling; AbobotulinumtoxinA (Dysport®) Reconstitution and Handling; IncobotulinumtoxinA (Xeomin®) Reconstitution and Handling; RimabotulinumtoxinB (Myobloc® in the United States, NeuroBloc® Outside the United States) Reconstitution and Handling; Injection Supplies; Needle Selection Chapter 4: Guidance Techniques for Botulinum Neurotoxin InjectionsAnatomic Reference Guides, Surface Anatomy, and Palpation Guidance; EMG Guidance; Electrical Stimulation Guidance; B-Mode Ultrasound; Combinations of Techniques; Other Guidance Techniques for BoNT Injections; Summary; Chapter 5: Phenol Nerve Blocks; Why Consider Phenol Neurolysis?; Phenol Mechanism of Action; Muscle Hypertonia; Pattern of Involvement; Injection Technique and Dosing; Musculocutaneous Nerve; Obturator Nerve; Tibial Motor Nerves; Summary; Section Two: Clinical Applications of Botulinum Neurotoxins Part I: Botulinum Neurotoxins for the Treatment of Muscle Overactivity Associated with Focal Dystonia Syndromes and Upper Motor Neuron SyndromesCraniofacial Dystonia; Chapter 6: Benign Essential Blepharospasm; Chapter 7: Botulinum Neurotoxin Therapy for Hemifacial Spasm; Chapter 8: Botulinum Neurotoxin Injections for Oromandibular Dystonias; Illustrations for Craniofacial Dystonia; Cervical Dystonia; Chapter 9: Botulinum Neurotoxin Injections for Cervical Dystonia; Illustrations for Cervical Dystonia; Upper Limb, Lower Limb, and Trunk Dystonia Chapter 10: Botulinum Neurotoxin for the Treatment of Idiopathic Primary Focal Limb DystoniaChapter 11: Botulinum Neurotoxin for Treatment of Muscle Overactivity Associated with Upper Motor Neuron Syndromes; Chapter 12: Botulinum Neurotoxin for the Treatment of Trunk Dystonia/Camptocormia; Chapter 13: Botulinum Neurotoxin Injections for the Treatment of Tremor; Illustrations for Upper Limb, Lower Limb, and Trunk Dystonia; Part II: Botulinum Neurotoxins for Neurosecretory Disorders; Chapter 14: Botulinum Neurotoxin Therapy for Problematic Sialorrhea; Condition Chapter 15: Botulinum Neurotoxin Therapy for Hyperhidrosis |
Record Nr. | UNINA-9910812965203321 |
New York, New York : , : Demos Medical, , 2015 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Musculoskeletal examination and joint injections techniques |
Autore | Fam Adel G |
Pubbl/distr/stampa | [Place of publication not identified], : Mosby Elsevier, 2006 |
Disciplina | 616.7/2075 |
Soggetto topico |
Diseases
Diagnostic Techniques and Procedures Injections Musculoskeletal Diseases Physical Examination Injections, Intra-Articular Drug Administration Routes Diagnosis Analytical, Diagnostic and Therapeutic Techniques and Equipment Drug Therapy Therapeutics |
ISBN | 0-323-03003-3 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Fam |
Record Nr. | UNISA-996212361903316 |
Fam Adel G | ||
[Place of publication not identified], : Mosby Elsevier, 2006 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. di Salerno | ||
|
Patient safety [[electronic resource] ] : HHS has taken steps to address unsafe injection practices, but more action is needed : report to the Ranking Member, Subcommittee on Health, Committee on Energy and Commerce, House of Representatives |
Pubbl/distr/stampa | [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2012] |
Descrizione fisica | 1 online resource (ii, 33 pages) |
Soggetto topico |
Patients - Safety measures - Government policy - United States
Injections |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Patient safety |
Record Nr. | UNINA-9910702363403321 |
[Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2012] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|